Home » Topics » Regulatory » Patents

Patents
RSS

5-HT1A receptor agonists with good potency and selectivity designed at Pierre Fabre

June 1, 1999

More on protein farnesyltransferase inhibitors in development at Merck

June 1, 1999

Pfizer researchers present selective inhibitors of urokinase and their use

June 1, 1999

Carbapenems from Merck especially useful against resistant bacteria

June 1, 1999

Alpha-aryl-N-alkylnitrones from Centaur useful for neurological, autoimmune, inflammatory disorders

May 31, 1999

Novel compounds for vitamin D-dependent disorders in development at Roche

May 31, 1999

Lilly discovers arylpiperazines acting as both 5-HT reuptake inhibitors, 5-HT1D antagonists

May 31, 1999

Roche discloses new bicyclic compounds as p38 MAP kinase inhibitors

May 31, 1999

Dual antagonists at 5-HT3 and 5-HT4 receptors for GI disorders

May 31, 1999

Potent and selective 5-HT1A receptor agonists developed at Pierre Fabre

May 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...